Sax Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Sell
6,662
-684
-9% -$39.3K 0.02% 387
2026
Q1
$396K Sell
7,346
-137
-2% -$7.99K 0.02% 334
2025
Q4
$404K Sell
7,483
-413
-5% -$19.9K 0.02% 335
2025
Q3
$356K Buy
7,896
+1,795
+29% +$83.8K 0.02% 326
2025
Q2
$282K Sell
6,101
-242
-4% -$11.9K 0.02% 352
2025
Q1
$387K Buy
6,343
+307
+5% +$17.9K 0.03% 251
2024
Q4
$341K Sell
6,036
-2,062
-25% -$115K 0.03% 246
2024
Q3
$419K Buy
8,098
+487
+6% +$22.8K 0.04% 176
2024
Q2
$316K Sell
7,611
-6,089
-44% -$272K 0.03% 203
2024
Q1
$743K Sell
13,700
-155
-1% -$7.9K 0.09% 88
2023
Q4
$711K Buy
13,855
+275
+2% +$14.4K 0.12% 92
2023
Q3
$788K Buy
13,580
+1,477
+12% +$90.5K 0.16% 81
2023
Q2
$774K Buy
12,103
+11
+0.1% +$738 0.15% 79
2023
Q1
$838K Buy
12,092
+284
+2% +$20K 0.18% 72
2022
Q4
$850K Sell
11,808
-1,400
-11% -$106K 0.2% 66
2022
Q3
$939K Sell
13,208
-372
-3% -$27K 0.24% 63
2022
Q2
$1.05M Sell
13,580
-1,429
-10% -$109K 0.27% 60
2022
Q1
$1.1M Sell
15,009
-2,787
-16% -$187K 0.27% 56
2021
Q4
$1.11M Buy
17,796
+461
+3% +$27K 0.23% 64
2021
Q3
$1.03M Buy
17,335
+2,668
+18% +$176K 0.24% 63
2021
Q2
$980K Sell
14,667
-46
-0.3% -$3K 0.34% 59
2021
Q1
$929K Sell
14,713
-329
-2% -$20.5K 0.34% 57
2020
Q4
$933K Buy
+15,042
New +$925K 0.43% 51

Other funds holding BMY

Sax Wealth Advisors's BMY Position: Q2 2026 in Review

Sax Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 9.3% in Q2 2026, selling an estimated $39.3K and leaving 6,662 shares worth $404K. The position accounts for 0.02% of the portfolio, ranked #387.

Sax Wealth Advisors first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.11M in Q4 2021. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sax Wealth Advisors held 6,662 shares of Bristol-Myers Squibb worth $404K as of Q2 2026.
  • Sax Wealth Advisors sold 684 Bristol-Myers Squibb shares in Q2 2026, an estimated $39.3K.
  • Bristol-Myers Squibb made up 0.02% of Sax Wealth Advisors's portfolio in Q2 2026, its #387 holding.
  • Sax Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Sax Wealth Advisors's Bristol-Myers Squibb position peaked at $1.11M in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.